No abstract

We investigated the biodegradation process of freshwater phytoplanktonic organic matter using incubation experiments, with special reference to changes in three major biomolecules: neutral aldoses, amino acids and fatty acids. The concentration of neutral aldoses decreased drastically relative to amino acids and fatty acids during the early decomposition phase (days 0-7), owing largely to the rapid decomposition of storage carbohydrate. This resulted in a temporary decrease in the C/N ratio of organic matter. During the late phase (days 7-60), however, the rate of decrease in neutral aldoses slowed, while the considerable decrease in amino acids and fatty acids continued. The inconspicuous change in amino acid composition was probably due to the fact that no protein and/or peptide is composed of a limited species of amino acid. Although the compositional variety of organic matter among the phytoplankton was clearly observed at the start of decomposition, it became obscure in the course of 60 days. This indicates that while the organic composition of the labile fraction of phytoplanktonic organic matter varies depending on the phytoplankton groups, the refractory fraction has similar composition. The addition of bacterial organic matter is likely another reason for the similar composition of the remaining organic matter at day 60.

A novel 2',3'-dihydroxy-p-terphenyl derivative, thelephantin O (TO), which has cancer-selective cytotoxicity, was isolated. This study investigated the underlying basis of the cytotoxicity of 2',3'-dihydroxy-p-terphenyl compounds in view of their ability to chelate metal ions. FeCl(2) significantly reduced TO-induced cytotoxicity, whereas several other salts of transition metals and alkaline-earth metals did not. A structure-activity relationship study using newly synthesized p-terphenyl derivatives revealed that o-dihydroxy substitution of the central benzene ring was necessary for both the cytotoxicity and Fe(2+) chelation of the compounds. Real-time PCR array and cell cycle analysis revealed that the TO-induced cytotoxicity was attributed to cell cycle arrest at the G1 phase via well-known cell cycle-mediated genes. The TO-induced changes in the cell cycle and gene expression were completely reversed by the addition of FeCl(2). Thus, it was concluded that Fe(2+) chelation occurs upstream in the pivotal pathway of 2',3'-dihydroxy-p-terphenyl-induced inhibition of cancer cell proliferation.

The lethal dosage of an extract of a toxic strain of Microcystis viridis or purified toxin, microcystin RR was determined against goldfish. The LD50 values of microcystin RR obtained by intraperitoneal injection into goldfish were just above 2 mg•kg-1 which was about 26 times higher than the known values for mice. Death of goldfish occurred rather slowly until 5th day, when the observation was terminated following injection of extract. The liver tissue was most severely affected by the intraperitoneal injection of toxin, and hemorrhage, swelling and finally blood pooling in the tissue were observed. Oral administration of Microcystis viridis as pellets mixed with the algae for 28 d did not cause any mortality but a few fish showed a slight liver damage.

We previously demonstrated that IL-18 and CCL11 were highly expressed in an NFSA tumor cell line that showed limited angiogenesis and severe necrosis. However, IL-18 was not responsible for the immune cell accumulation and necrosis. Here, we attempted to clarify the relevance of CCL11 in angiogenesis and tumor formation. We established CCL11-overexpressing MS-K cell clones (MS-K-CCL11) to assess the role of CCL11 in immune cell accumulation and angiogenesis. The MS-K-CCL11 cells did not form tumors in mice. MS-K-CCL11-conditioned medium (CM) and recombinant CCL11 induced macrophage and eosinophil differentiation from bone marrow cells. The MS-K-CCL11-CM effectively recruited the differentiated eosinophils. Furthermore, the eosinophils damaged the MS-K, NFSA and endothelial cells in a dose-dependent manner. Administration of an antagonist of CCR3, a CCL11 receptor, to NFSA tumor-bearing mice restored the blood vessel formation and blocked the eosinophil infiltration into the NFSA tumors. Furthermore, other CCL11-overexpressing LM8 clones were established, and their tumor formation ability was reduced compared to the parental LM8 cells, accompanied by increased eosinophil infiltration, blockade of angiogenesis and necrosis. These results indicate that CCL11 was responsible for the limited angiogenesis and necrosis by inducing and attracting eosinophils in the tumors.